410 related articles for article (PubMed ID: 14749625)
1. Immunotherapy of surgical malignancies.
Morse MA; Lyerly HK; Clay TM; Abdel-Wahab O; Chui SY; Garst J; Gollob J; Grossi PM; Kalady M; Mosca PJ; Onaitis M; Sampson JH; Seigler HF; Toloza EM; Tyler D; Vieweg J; Yang Y
Curr Probl Surg; 2004 Jan; 41(1):15-132. PubMed ID: 14749625
[No Abstract] [Full Text] [Related]
2. How much help does a vaccine-induced T-cell response need?
Weber JS; Mulé JJ
J Clin Invest; 2001 Mar; 107(5):553-4. PubMed ID: 11238555
[No Abstract] [Full Text] [Related]
3. Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2).
Acres B
J BUON; 2007 Sep; 12 Suppl 1():S71-5. PubMed ID: 17935281
[TBL] [Abstract][Full Text] [Related]
4. DC-based cancer vaccines.
Gilboa E
J Clin Invest; 2007 May; 117(5):1195-203. PubMed ID: 17476349
[TBL] [Abstract][Full Text] [Related]
5. Active and passive immunotherapy: vaccines and antibodies.
Oosterwijk E; Divgi C; Bander NH
BJU Int; 2007 May; 99(5 Pt B):1301-4. PubMed ID: 17441928
[No Abstract] [Full Text] [Related]
6. Tumor escape from the immune response: a major hurdle for successful immunotherapy of cancer?
Chouaib S
Tunis Med; 2005 Dec; 83 Suppl 12():7-10. PubMed ID: 16430055
[No Abstract] [Full Text] [Related]
7. Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: more than one plus one?
Thanendrarajan S; Nowak M; Abken H; Schmidt-Wolf IG
Leuk Res; 2011 Sep; 35(9):1136-42. PubMed ID: 21652069
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapeutic approaches for renal cancer.
Pizza G; de Vinci C; Viza D
Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765
[No Abstract] [Full Text] [Related]
9. Renal cell carcinoma: recent progress and future directions.
Mulders P; Figlin R; deKernion JB; Wiltrout R; Linehan M; Parkinson D; deWolf W; Belldegrun A
Cancer Res; 1997 Nov; 57(22):5189-95. PubMed ID: 9371523
[No Abstract] [Full Text] [Related]
10. Adenovirus as vehicle for anticancer genetic immunotherapy.
Gallo P; Dharmapuri S; Cipriani B; Monaci P
Gene Ther; 2005 Oct; 12 Suppl 1():S84-91. PubMed ID: 16231059
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
[TBL] [Abstract][Full Text] [Related]
12. Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinoma.
Dudek AZ; Mescher MF; Okazaki I; Math VT; Luo X; Curtsinger JM; Miller JS
Am J Clin Oncol; 2008 Apr; 31(2):173-81. PubMed ID: 18391603
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for glioma: promises and challenges.
Han SJ; Zygourakis C; Lim M; Parsa AT
Neurosurg Clin N Am; 2012 Jul; 23(3):357-70. PubMed ID: 22748649
[TBL] [Abstract][Full Text] [Related]
14. New approaches to immunoprevention and immunotherapy of neoplasms.
Glushkov AN
Russ J Immunol; 2002 Oct; 7(3):219-28. PubMed ID: 12674931
[TBL] [Abstract][Full Text] [Related]
15. Cellular vaccine therapies for cancer.
Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D
Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681
[No Abstract] [Full Text] [Related]
16. Vaccines for colorectal cancer and renal cell carcinoma.
Kabaker K; Shell K; Kaufman HL
Cancer J; 2011; 17(5):283-93. PubMed ID: 21952277
[TBL] [Abstract][Full Text] [Related]
17. Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?
Van Gool S; De Vleeschouwer S
Expert Rev Neurother; 2012 Oct; 12(10):1173-6. PubMed ID: 23082731
[No Abstract] [Full Text] [Related]
18. Vaccines to treat cancer--an old approach whose time has arrived.
Hellstrom KE; Hellstrom I
J Cell Biochem; 2007 Oct; 102(2):291-300. PubMed ID: 17729239
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of melanoma.
Parmiani G; Castelli C; Rivoltini L; Casati C; Tully GA; Novellino L; Patuzzo A; Tosi D; Anichini A; Santinami M
Semin Cancer Biol; 2003 Dec; 13(6):391-400. PubMed ID: 15001157
[TBL] [Abstract][Full Text] [Related]
20. Current developments of immunotherapy in the clinic.
Antonia S; Mulé JJ; Weber JS
Curr Opin Immunol; 2004 Apr; 16(2):130-6. PubMed ID: 15023403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
